Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study
Launched by UNIVERSITI TUNKU ABDUL RAHMAN · Feb 27, 2024
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Ultrapulse is a is a laser beauty device using erbium-doped yttrium aluminium garnet laser (er:YAG). Er:YAG laser is a laser with wavelength of 2940nm which is able to penetrate into the dermis to a depth of 3-4 mm, and energy absorption occurs in the area of the dermal papilla, resulting in an increase in blood circulation of the papilla and activation of metabolism in the hair follicle. It generates multiple micro pores at the epidermal layer that enhances the absorption of the active substances that help to stimulate hair growth developed by Lyzer Co. Ltd in Korea.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patient with androgenic alopecia with severity of Norwood-Hamilton Scale II to VI for male and Ludwig Scale I to III for female
- Exclusion Criteria:
- • Use of topical or systemic medications affecting hair growth within the 6 months before recruitment
- • Previous hair transplantation, underwent scalp reconstruction procedure, hair braiding or scalp tattoo
About Universiti Tunku Abdul Rahman
Universiti Tunku Abdul Rahman (UTAR) is a leading Malaysian institution dedicated to advancing education and research in various fields, including health sciences. As a clinical trial sponsor, UTAR is committed to conducting high-quality, ethically sound research that contributes to the advancement of medical knowledge and healthcare practices. The university leverages its diverse expertise and state-of-the-art facilities to facilitate innovative clinical studies, ensuring adherence to regulatory standards and promoting collaboration with local and international research communities. Through its initiatives, UTAR aims to enhance patient care and foster a culture of research excellence within the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bandar Puchong Jaya, Selangor, Malaysia
Patients applied
Trial Officials
Yang Mooi Lim, PhD
Principal Investigator
Universiti Tunku Abdul Rahman
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported